DAmico, D., Fouassier, A., Faith, J., Hennighausen, N., Brandt, M
Orders ship same-day via USPS Express with discreet packaging
Selected Clinical Trial Activity BPC-157 + TB-500 is a research-grade compound that has been studied in laboratory settings but has not undergone full clinical development
91 In addition, lactylation at K91 of TFEB inhibits its interaction with the E3 ubiquitin ligase WWP2, leading to reduced ubiquitination and proteasomal degradation of TFEB, thereby resulting in enhanced TFEB activity
When the 60 mg vial makes financial sense You are at a maintenance dose of 7.5 mg or higher (you will use the vial within the stability window) You have already titrated using smaller vials and know your target dose You are comfortable with reconstitution and precise syringe measurements You can store the vial properly for the entire duration When smaller vials make more sense You are just starting tirzepatide and do not know your dose yet You are microdosing at very low amounts (1-2.5 mg) You want to test a new vendor or batch before committing to a large purchase Your storage conditions are not ideal (unreliable refrigeration, travel) Syringe selection and measurement precision The syringe you use matters more than most people realize
